SkinBioTherapeutics plc (AIM:SBTX)
London · Delayed Price · Currency is GBP · Price in GBX 9.56
+0.06 (0.63%)
At close: Mar 4, 2026
SkinBioTherapeutics Market Cap
SkinBioTherapeutics has a market cap or net worth of 24.78 million as of March 4, 2026. Its market cap has decreased by -47.73% in one year.
Market Cap
24.78M
Enterprise Value
20.99M
Revenue
4.64M
Ranking
n/a
PE Ratio
n/a
Stock Price
9.56
Market Cap Chart
Since April 5, 2017, SkinBioTherapeutics's market cap has increased from 15.73M to 24.78M, an increase of 57.52%. That is a compound annual growth rate of 5.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 24.62M | -39.59% |
| Dec 31, 2025 | 40.76M | -3.56% |
| Dec 31, 2024 | 42.26M | 45.57% |
| Dec 29, 2023 | 29.03M | 8.17% |
| Dec 30, 2022 | 26.84M | -59.24% |
| Dec 31, 2021 | 65.85M | 79.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Faron Pharmaceuticals Oy | 61.94M |
| hVIVO | 54.57M |
| Ondine Biomedical | 53.25M |
| ImmuPharma | 38.91M |
| Poolbeg Pharma | 31.73M |
| Arecor Therapeutics | 27.37M |
| Aptamer Group | 23.60M |
| Sareum Holdings | 21.40M |